10 Common Mistakes in Pathology NEET PG — And How to Avoid Them

Version 1.0 — Published March 2026

Why pathology mistakes are costly

Pathology contributes 18-24 questions to NEET PG, making it the second-highest-weighted pre-clinical subject after pharmacology (2021-2024 pattern analysis). Unlike biochemistry, which tests isolated facts, pathology questions test pattern recognition across histology, cytogenetics, and clinical correlation. A single conceptual error — say, mixing up caseating versus non-caseating granulomas — can cost you 2-3 questions in the same paper.

The ten mistakes below are the patterns that consistently appear in wrong-answer analyses from AIIMS, PGI, and private coaching institutes. Each mistake includes what students typically do, why it fails, the correct approach, and an example MCQ demonstrating the trap.

For a comprehensive pathology strategy, pair this guide with the NEET PG pathology high-yield topics and the histopathology granuloma image MCQ walkthrough.

Mistake 1: Confusing tumor markers across GI and non-GI malignancies

What students do: Memorize a single tumor marker for each cancer without understanding that many markers overlap across multiple tumors.

Why it is wrong: Tumor markers are not specific — they are elevated in several conditions, including benign ones. AFP is raised in hepatocellular carcinoma (HCC) AND nonseminomatous germ cell tumors (yolk sac tumor) AND neural tube defects in pregnancy. CEA is raised in colorectal carcinoma but also in pancreatic, breast, lung cancers, and in smokers without cancer. CA 19-9 is raised in pancreatic cancer but also in cholangiocarcinoma and biliary obstruction (even without malignancy). PSA is raised in prostate cancer but also in BPH and prostatitis.

Correct approach: Build a two-column table: Marker → Cancer (primary association) + other conditions. Know that tumor markers are used for monitoring treatment response and detecting recurrence, NOT primary diagnosis.

Example MCQ: A 52-year-old man presents with obstructive jaundice, weight loss of 8 kg, and a palpable gallbladder (Courvoisier sign). His CA 19-9 is 450 U/mL. The most likely diagnosis is:

• (a) Hepatocellular carcinoma
• (b) Pancreatic head carcinoma
• (c) Gastric carcinoma
• (d) Colorectal carcinoma

Answer: (b). CA 19-9 is the tumor marker most strongly associated with pancreatic adenocarcinoma. The clinical triad of painless obstructive jaundice + palpable gallbladder + weight loss supports pancreatic head carcinoma. HCC marker is AFP; colorectal is CEA.

Mistake 2: Mixing up histological patterns of carcinomas

What students do: Recognize only one histological pattern per carcinoma and miss variant patterns that NBE tests.

Why it is wrong: Many carcinomas show multiple histological patterns. Breast ductal carcinoma can be scirrhous (desmoplastic with fibrous stroma), medullary (sheets of anaplastic cells with lymphocytic infiltrate — better prognosis), mucinous (extracellular mucin pools), or papillary. Renal cell carcinoma has clear cell (most common, VHL gene), papillary, chromophobe, and collecting duct variants — each with different genetic associations and prognosis.

Correct approach: For each major carcinoma, learn the 2-3 most tested histological variants with their key distinguishing features.

Example MCQ: A 58-year-old woman presents with a thyroid mass. Histology shows ground-glass nuclei with intranuclear inclusions and psammoma bodies. The most likely diagnosis is:

• (a) Follicular thyroid carcinoma
• (b) Medullary thyroid carcinoma
• (c) Papillary thyroid carcinoma
• (d) Anaplastic thyroid carcinoma

Answer: (c). Orphan Annie eye nuclei (ground-glass, intranuclear inclusions) and psammoma bodies are pathognomonic of papillary thyroid carcinoma — the most common thyroid malignancy with excellent prognosis (>95% 10-year survival).

Mistake 3: Confusing staging and grading of tumors

What students do: Use staging and grading interchangeably, or mix up which system applies to which tumor.

Why it is wrong: Staging describes the anatomical extent of tumor spread — tumor size (T), regional lymph nodes (N), and distant metastasis (M) in the TNM system. Grading describes the histological differentiation — how closely tumor cells resemble normal cells. These are orthogonal concepts: a small, well-differentiated tumor (low stage, low grade) behaves very differently from a small poorly-differentiated tumor (low stage, high grade).

Correct approach: Remember: stage = spread (anatomy), grade = ugly (histology). Learn tumor-specific systems:

Example MCQ: In a patient with breast carcinoma, T2N1M0 indicates:

• (a) Tumor grade 2 with 1 lymph node involvement
• (b) Tumor 2-5 cm with regional lymph node involvement, no distant metastasis
• (c) Tumor size 2 cm, grade 1, no metastasis
• (d) Stage II with one nodule

Answer: (b). TNM is a staging system. T2 = tumor 2-5 cm. N1 = 1-3 ipsilateral axillary nodes involved. M0 = no distant metastasis. Grade is a separate histological parameter (Bloom-Richardson for breast cancer).

Mistake 4: Confusing primary vs secondary amyloidosis

What students do: Assume all amyloid is the same because it all stains with Congo red.

Why it is wrong: The two main amyloid types differ in protein composition, underlying disease, and management. AL amyloidosis (primary) is composed of immunoglobulin light chains (kappa or lambda) — associated with multiple myeloma and monoclonal gammopathy. AA amyloidosis (secondary, reactive) is composed of serum amyloid A protein — associated with chronic inflammation (rheumatoid arthritis, tuberculosis, chronic osteomyelitis, familial Mediterranean fever).

Correct approach: Learn the classification table and the potassium permanganate test for differentiation:

Other tested amyloid types: ATTR (transthyretin — familial amyloid cardiomyopathy), beta-2 microglobulin (dialysis-associated), A-beta (Alzheimer disease), amylin (type 2 diabetes islet deposits).

Example MCQ: A 62-year-old woman with long-standing rheumatoid arthritis develops proteinuria and renal failure. Renal biopsy shows amyloid deposits that lose Congo red staining after potassium permanganate treatment. The most likely amyloid type is:

• (a) AL amyloid
• (b) AA amyloid
• (c) ATTR amyloid
• (d) Beta-2 microglobulin amyloid

Answer: (b). AA amyloidosis is associated with chronic inflammation (rheumatoid arthritis here) and characteristically loses Congo red affinity after potassium permanganate treatment. AL amyloid retains Congo red affinity.

Mistake 5: Mixing up chromosomal translocations

What students do: Try to memorize chromosomal translocations in isolation and confuse similar-looking numbers (t(9;22) vs t(15;17) vs t(8;14)).

Why it is wrong: NEET PG tests 2-3 translocation questions per paper. Getting them right requires recognizing the gene fusion, not just the chromosome numbers. t(9;22) BCR-ABL is CML (Philadelphia chromosome); t(15;17) PML-RARA is acute promyelocytic leukemia (APL, AML-M3) treated with ATRA; these look similar in numbers but are completely different diseases with different treatments.

Correct approach: Build a single table linking translocation → gene fusion → disease → treatment implication. Focus on the five translocations below — they cover 90% of NEET PG questions.

Example MCQ: A 6-year-old boy presents with a large jaw mass. Biopsy shows sheets of small non-cleaved lymphocytes with a starry-sky appearance and Ki-67 proliferation index close to 100%. The most likely translocation is:

• (a) t(9;22)
• (b) t(15;17)
• (c) t(14;18)
• (d) t(8;14)

Answer: (d). Starry-sky pattern (macrophages with apoptotic debris within a background of lymphoma cells) + jaw mass in a child + high Ki-67 = Burkitt lymphoma. The classic translocation is t(8;14) with MYC oncogene rearrangement.

Mistake 6: Confusing Reed-Sternberg cell variants

What students do: Remember only the classic bilobed RS cell and miss the variants that define specific Hodgkin lymphoma subtypes.

Why it is wrong: NEET PG tests Hodgkin lymphoma subtyping through RS variant recognition. Missing that lacunar cells indicate nodular sclerosis HL (the most common subtype) or that popcorn cells indicate nodular lymphocyte-predominant HL (NLPHL — CD20+ but CD15-, CD30-) costs direct marks.

Correct approach: Memorize RS variants and their associated HL subtypes:

Example MCQ: A 25-year-old man presents with mediastinal lymphadenopathy. Biopsy shows collagen bands dividing the lymph node into nodules, with RS cells sitting in clear lacunar spaces. The most likely diagnosis is:

• (a) Nodular sclerosis Hodgkin lymphoma
• (b) Mixed cellularity Hodgkin lymphoma
• (c) Lymphocyte-rich Hodgkin lymphoma
• (d) Nodular lymphocyte-predominant Hodgkin lymphoma

Answer: (a). Lacunar cells + collagen bands dividing the node = nodular sclerosis HL. This is the most common Hodgkin lymphoma subtype, typically presenting in young adults with mediastinal involvement.

Mistake 7: Confusing types of necrosis

What students do: Use "necrosis" as a single concept and miss the specific type being tested.

Why it is wrong: Necrosis type points to etiology. Coagulative in kidney → ischemic infarct. Liquefactive in brain → cerebral infarct or abscess. Caseous in lung → tuberculosis. Fat necrosis in pancreas → acute pancreatitis. Fibrinoid in blood vessels → vasculitis or malignant hypertension.

Correct approach: Learn the six necrosis types and their classic associations:

Example MCQ: A 45-year-old man dies of acute myocardial infarction. Histology of the infarcted myocardium 3 days later would show:

• (a) Liquefactive necrosis
• (b) Caseous necrosis
• (c) Coagulative necrosis
• (d) Fat necrosis

Answer: (c). Ischemic infarcts in most organs (including heart) show coagulative necrosis — preserved tissue architecture with loss of nuclei and eosinophilic cytoplasm. The exception is the brain, which shows liquefactive necrosis.

Mistake 8: Misreading immunohistochemistry (IHC) markers

What students do: Memorize IHC markers in isolation without understanding the panel pattern that differentiates tumors.

Why it is wrong: NEET PG tests IHC through differential diagnosis panels. A tumor that is CK+, TTF-1+, napsin A+ is lung adenocarcinoma. A tumor that is CK+, CDX-2+ is colorectal or upper GI. A tumor that is S100+, HMB-45+, Melan-A+ is melanoma. Missing the panel pattern means missing the answer.

Correct approach: Learn IHC by tumor family:

Organ-specific markers: TTF-1 (lung adeno, thyroid), CDX-2 (GI), PSA/PSAP (prostate), ER/PR/HER2 (breast), WT-1 (ovarian serous, mesothelioma).

Example MCQ: A lymph node biopsy shows a malignant tumor positive for cytokeratin, TTF-1, and napsin A. The most likely primary site is:

• (a) Breast
• (b) Lung (adenocarcinoma)
• (c) Colon
• (d) Prostate

Answer: (b). CK+ indicates epithelial origin (carcinoma). TTF-1 and napsin A together are highly specific for lung adenocarcinoma. Breast would be GATA3+ or ER/PR+; colon CDX-2+; prostate PSA+.

Mistake 9: Confusing hyperplasia, dysplasia, and neoplasia

What students do: Use these terms interchangeably when they represent distinct stages of cellular change with different clinical implications.

Why it is wrong: The continuum is: normal → hyperplasia → dysplasia (low grade → high grade) → carcinoma in situ → invasive carcinoma. Each stage has different reversibility and cancer risk. Calling a hyperplastic prostate "dysplastic" or calling dysplasia "cancer" changes management.

Correct approach: Learn the precise definitions:

Note: anaplasia is the hallmark of malignant neoplasia — loss of cellular differentiation, marked pleomorphism, abnormal mitoses.

Example MCQ: A Pap smear shows atypical cells with high N/C ratio, hyperchromatic nuclei, and disordered architecture involving the full thickness of the cervical epithelium, but no stromal invasion. The most appropriate terminology is:

• (a) Cervical intraepithelial neoplasia 1 (CIN 1)
• (b) Cervical intraepithelial neoplasia 2 (CIN 2)
• (c) Cervical intraepithelial neoplasia 3 / carcinoma in situ
• (d) Invasive squamous cell carcinoma

Answer: (c). Full-thickness atypia without invasion = CIN 3 / carcinoma in situ. CIN 1 = lower one-third dysplasia; CIN 2 = lower two-thirds dysplasia; invasive carcinoma requires basement membrane penetration.

Mistake 10: Wrong grading systems for different tumors

What students do: Apply Bloom-Richardson to prostate or Gleason to breast — mixing up which grading system goes with which tumor.

Why it is wrong: NBE tests grading system knowledge directly. Each system is specific to one tumor and uses specific histological criteria.

Correct approach: Memorize the tumor-specific grading table:

Example MCQ: A prostate biopsy shows two dominant histological patterns — pattern 4 in 60% of the tumor and pattern 3 in 30%. The Gleason score is:

• (a) 3 + 4 = 7
• (b) 4 + 3 = 7
• (c) 4 + 4 = 8
• (d) 3 + 3 = 6

Answer: (b). Gleason score is the sum of the two most prevalent architectural patterns. The most prevalent pattern is listed first (4), followed by the second most prevalent (3) = 4+3 = 7. Gleason 4+3 has worse prognosis than 3+4 despite the same numerical score because the dominant pattern is more aggressive.

Comparison table: mistake vs correct approach

Self-check checklist

Before your next pathology revision session, verify you can answer each of these without looking:

• Name the primary cancer and 2 other causes of elevated AFP, CEA, CA 19-9, PSA, CA 125
• Distinguish AL from AA amyloidosis (precursor, associations, permanganate test)
• Identify translocations: t(9;22), t(15;17), t(14;18), t(8;14), t(11;14) and their diseases
• Distinguish classical RS cells, lacunar cells, popcorn cells and their HL subtypes
• Name 6 types of necrosis with their classic organ associations
• Match IHC panels to tumor families (epithelial, mesenchymal, lymphoid, melanoma, neuroendocrine)
• Describe the progression: hyperplasia → dysplasia → carcinoma in situ → invasive
• Apply Gleason to prostate, Bloom-Richardson to breast, Fuhrman to RCC

If you hesitate on more than 2 items, revisit the corresponding mistake section above.

Frequently asked questions

How many pathology questions appear in NEET PG?

Pathology contributes 18-24 questions in NEET PG (2021-2024 pattern analysis), making it the second-highest-weighted pre-clinical subject after pharmacology. Roughly 5-7 questions directly test histological pattern recognition, 3-4 test tumor markers and staging, 3-4 test hematology morphology, and the remaining questions are clinical-pathological correlations. Mistakes in pathology often cascade — a confused histological pattern can cost you 2-3 questions across the same paper.

What is the most common pathology mistake in NEET PG?

Confusing staging with grading is the single most costly mistake. Students mix up which describes the extent of tumor spread (staging — TNM, Dukes, Ann Arbor) versus the degree of cellular differentiation (grading — histological appearance). The rule: stage = spread (anatomy and lymph nodes), grade = ugly (how abnormal the cells look microscopically). Stage predicts prognosis more strongly than grade for most solid tumors.

How do I memorize chromosomal translocations without confusing them?

Group translocations by the common partner chromosomes and by disease pattern. t(9;22) BCR-ABL is CML (the Philadelphia chromosome) — also in 25% of adult B-ALL. t(15;17) PML-RARA is acute promyelocytic leukemia (APL, AML-M3) — treated with ATRA. t(14;18) BCL2-IgH is follicular lymphoma. t(8;14) MYC-IgH is Burkitt lymphoma. t(11;14) cyclin D1-IgH is mantle cell lymphoma. Make a single flashcard table with translocation → gene fusion → disease — this gives you 90% of NEET PG translocation questions.

How can I tell primary from secondary amyloidosis on biopsy?

Both show apple-green birefringence under polarized light after Congo red staining — that confirms amyloid but does not distinguish the type. Primary amyloidosis (AL amyloid) is made of immunoglobulin light chains (kappa or lambda), associated with multiple myeloma or monoclonal gammopathy. Secondary amyloidosis (AA amyloid) is made of serum amyloid A protein, associated with chronic inflammation — rheumatoid arthritis, tuberculosis, chronic osteomyelitis, familial Mediterranean fever. The key distinguisher is potassium permanganate treatment — AA amyloid loses Congo red affinity, AL amyloid retains it.

What is the difference between hyperplasia, dysplasia, and neoplasia?

Hyperplasia is a reversible increase in the number of normally-appearing cells in response to a stimulus (physiological or pathological). Dysplasia is disordered cellular growth with architectural and cytological atypia — reversible in early stages, but carries a risk of progression to cancer. Neoplasia is autonomous, irreversible cellular proliferation that does not respond to normal growth controls. The progression is: normal → hyperplasia → dysplasia (low grade → high grade) → carcinoma in situ → invasive carcinoma. Only invasion through the basement membrane defines invasive cancer.

How should I approach immunohistochemistry (IHC) questions in NEET PG?

Learn IHC by tumor family, not isolated markers. Epithelial tumors: cytokeratin positive. Mesenchymal tumors: vimentin positive. Lymphoid tumors: LCA (CD45) positive. Melanocytic tumors: S100, HMB-45, Melan-A positive. Neuroendocrine tumors: chromogranin, synaptophysin, CD56 positive. Specific tumor markers: TTF-1 (lung adenocarcinoma, thyroid), CDX-2 (GI tract), PSA (prostate), GFAP (glial tumors), desmin (muscle). Most NEET PG IHC questions test 2-3 markers at a time — know the panel pattern, not every marker.

What are the classic Reed-Sternberg cell variants and their associated Hodgkin lymphoma subtypes?

The classic Reed-Sternberg (RS) cell is large with bilobed nuclei and prominent eosinophilic nucleoli — the owl-eye appearance. Variants: (1) Lacunar cells — RS in an artifactual clear space; characteristic of nodular sclerosis Hodgkin lymphoma (the most common subtype). (2) Popcorn cells (L&H cells) — small, folded, multilobated nuclei; characteristic of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), which is CD20+, CD15-, CD30-. (3) Mummified cells — shrunken, deeply staining RS cells. (4) Mononuclear Hodgkin cells — single-nucleus form of RS cell. Classical RS (CD15+, CD30+) and variants define classical HL.

What are the four types of necrosis and how are they distinguished?

Coagulative necrosis preserves tissue architecture (ghost outlines of cells) with loss of nuclei — characteristic of ischemic infarcts in most organs (heart, kidney, spleen). Liquefactive necrosis shows complete loss of tissue architecture with liquid debris — characteristic of brain infarcts and bacterial abscesses. Caseous necrosis shows amorphous, cheese-like, eosinophilic, acellular material — characteristic of tuberculosis and fungal granulomas. Fat necrosis shows saponified fat with calcium deposits (chalky white areas) — characteristic of acute pancreatitis and trauma. Two others tested: fibrinoid necrosis (immune complex deposition, vasculitis, rheumatic fever) and gangrenous necrosis (coagulative or liquefactive with superadded bacterial infection).

Sources and references

1. Robbins and Cotran Pathologic Basis of Disease, 10th Edition (Kumar, Abbas, Aster, 2021) — comprehensive pathology reference for neoplasia, tumor markers, staging/grading, amyloidosis, and necrosis types.
2. Rosai and Ackerman's Surgical Pathology, 11th Edition (Goldblum et al., 2018) — reference for histological patterns of carcinomas, IHC interpretation, and lymphoma subtyping.
3. Harsh Mohan, Textbook of Pathology, 8th Edition (2019) — standard Indian pathology textbook for NEET PG, aligned with NBE question patterns.

Master pathology patterns by practicing MCQs that test these exact trap points. Start with the pathology subject page, review the NEET PG pathology high-yield topics, and work through the histopathology granulomas image MCQ walkthrough for granuloma pattern recognition. Ready for unlimited AI-powered MCQs? Explore NEETPGAI Pro.

Build your personalized pathology study plan with the AI planner — it identifies your weak topics and schedules targeted revision.

---

Written by: NEETPGAI Editorial Team Reviewed by: Pending SME Review Last reviewed: March 2026

This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.